2-(5-Bromopyridin-2-yl)-1,2,3,4-tetrahydroisoquinoline

Catalog No. :
ACSKGY787
CAS No. :
553679-54-2
Molecular Formula :
C14H13BrN2
Molecular Weight :
289.18

IUPAC Name:2-(5-bromopyridin-2-yl)-1,2,3,4-tetrahydroisoquinoline

2-(5-Bromopyridin-2-yl)-1,2,3,4-tetrahydroisoquinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$139.00Login to see priceInquiryInquiry
5g95%$418.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(5-Bromopyridin-2-yl)-1,2,3,4-tetrahydroisoquinoline
IUPAC Name2-(5-bromopyridin-2-yl)-1,2,3,4-tetrahydroisoquinoline
MDL No.MFCD13476751
Molecular FormulaC14H13BrN2
Molecular Weight289.18
SMILESBrC1=CN=C(N2CC3=C(C=CC=C3)CC2)C=C1
InChI KeyGNLAIRZHEAKECW-UHFFFAOYSA-N
Synonym2-(5-Bromo-2-pyridinyl)-1,2,3,4-tetrahydroisoquinoline;2-(5-BROMOPYRIDIN-2-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE;2-(5-bromopyridin-2-yl)-3,4-dihydro-1H-isoquinoline;Isoquinoline, 2-(5-bromo-2-pyridinyl)-1,2,3,4-tetrahydro-
CAS No.553679-54-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSKGY787 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNBSC893 route compound structure diagram
    ACNBSC893223463-13-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSKGY787 route product structure diagram
    ACSKGY787553679-54-2
Inquiry

2. ACSKGY787 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSKGY787 route product structure diagram
    ACSKGY787553679-54-2
Inquiry

Comments (0)